Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Arcus Biosciences, Inc. Common Stock
(NY:
RCUS
)
28.76
-1.20 (-4.01%)
Streaming Delayed Price
Updated: 1:10 PM EDT, Jul 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences, Inc. Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Here's Why Arcus Biosciences Stock Is Rising Today
↗
June 24, 2021
Investors expecting Gilead Sciences to license Arcus Biosciences' lead asset could be in for an unpleasant surprise.
Via
The Motley Fool
Arcus Biosciences Rockets, But Vague Update In Cancer Study Divides Analysts
↗
June 24, 2021
Arcus Biosciences offered a vague update on its lung cancer regimens Wednesday, but RCUS stock rocketed on Thursday.
Via
Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; Accenture Reports Upbeat Q3 Results
↗
June 24, 2021
Following the market opening Thursday, the Dow traded up 0.76% to 34,130.38 while the NASDAQ rose 0.75% to 14,379.10. The S&P also rose, gaining 0.54% to 4,264.62. The U.S....
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 24, 2021
Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus...
Via
Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
↗
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
↗
June 24, 2021
Goldman Sachs boosted Lear Corporation (NYSE:LEA) pr...
Via
Benzinga
25 Stocks Moving in Thursday's Pre-Market Session
↗
June 24, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its...
Via
Benzinga
7 Stocks Moving In Wednesday's After-Hours Session
↗
June 23, 2021
Gainers Applied Genetic Technologies (NASDAQ: AGTC) shares are trading higher after the company announced that it plans to release 12-month data for adult patients and low-dose...
Via
Benzinga
Anti-TIGIT Domvanalimab-Based Combinations Showed Encouraging Clinical Activity in People with Metastatic, PDL1-High Non-Small Cell Lung Cancer at First Interim Analysis of Arcus Biosciences’ Randomized Phase 2 ARC-7 Study
June 23, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
June 09, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
May 25, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Presents Early Data from ARC-6, a Phase 1b/2 Study Evaluating Etrumadenant-Based Combinations in Metastatic Castrate-Resistant Prostate Cancer at the 2021 ASCO Annual Meeting
May 19, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
May 11, 2021
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Reports First Quarter 2021 Financial Results and Provides Operational Highlights
May 05, 2021
From
Arcus Biosciences
Via
Business Wire
Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More
↗
May 02, 2021
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders took advantage of recent public...
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
April 26, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting
April 10, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
April 09, 2021
From
Arcus Biosciences
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit